NewsBenzinga브리스톨 마이어스 스퀴브, MSToronto 2026에서 졸라캡타진 오토류셀 1상 임상시험 다발성경화증 그룹의 중간 안전성 및 유효성 데이터 발표 브리스톨 마이어스 스퀴브, MSToronto 2026에서 졸라캡타진 오토류셀 1상 임상시험 다발성경화증 그룹의 중간 안전성 및 유효성 데이터 발표 Benzinga 2026.10.23 14:33 (GMT+0) Open on Benzinga Other news Ark Invest Makes Big Crypto-Related Buys Yesterday While Selling $84.8M in Nvidia Stock Abraxas Capital Closes Most of Its Hyperliquid Shorts, Account Value Down to Just $22.4 Million Nvidia Falls 35% From Record High, Short Sellers Sit on $24 Billion in Paper Profits Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory Evernorth Has Written Down Its Pre-Listing XRP Holdings by 60%
Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips
Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory